March 31, 2026
Bryan Weselman’s Abstract While new treatment options for metastatic melanoma that activate the immune system to target cancer have helped some patients live longer,...
Joy Xie’s Abstract Skin cancer is the most common cancer in the United States, and nearly one in five Americans will develop it during their lifetime. While most pr...
Dan Erkes‘s Abstract Melanoma is the most lethal skin cancer, leading to an estimated 8,290 deaths and 100,640 new cases in 2024. Melanoma was traditionally ...
Daniel Hirschhorn‘s Abstract Immunotherapy has greatly improved survival for people with melanoma, but many patients also experience harmful side effects wh...
Kenneth Hu‘s Abstract Immunotherapies including immune checkpoint blockade (ICB) have seen remarkable success in the clinic. Unfortunately, many patients with late-st...
Emily Bernstein‘s Abstract Melanoma is the most lethal skin cancer, and the success of current therapies remains limited. To better tailor melanoma treatments, we m...
Lisa Cannon-Albright‘s Abstract Analysis of large families with more disease than expected has been shown to be a powerful way to identify cancer predisposition g...
Mathieu Desaunay‘s Abstract Skin cancer is one of the most common types of cancer, with melanoma being the deadliest form. In the United States, approximately 104,9...
Thorsten Mempel‘s Abstract While immunotherapy has greatly improved the survival for patients with melanoma of the sun-exposed skin, especially for those with adva...
Hee Won Yang‘s Abstract Melanoma is an aggressive type of skin cancer known for its rapid spread and frequent resistance to current treatments. Many advanced melanoma...
Craig Ceol‘s Abstract The use of immunotherapies has revolutionized treatment for late-stage melanoma patients. These therapies have extended survival for many patien...
Jaclyn Roland-McGowan’s Abstract This research project explores how different versions of a patient decision aid can help people make informed choices about their ski...
Apr 17, 2026 ET - Apr 19, 2026
Apr 19, 2026 PT
May 02, 2026 PT
May 09, 2026 ET
